Contract 75D30125D20399
Astrazeneca Pharmaceuticals Lp · Department Of Health And Human Services · November 17, 2025
Astrazeneca Pharmaceuticals Lp was awarded a federal contract by Department Of Health And Human Services (Centers For Disease Control And Prevention) on November 17, 2025 for $5,000 of work in pharmaceutical preparation manufacturing. It was awarded under full and open competition. It uses firm fixed-price contract pricing. If all options are exercised, the contract could reach $9.05 million.
Contract details
- PIID
- 75D30125D20399
- Award type
- —
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 325412 · Pharmaceutical Preparation Manufacturing
- Product / service
- Drugs And Biologicals
- First action
- November 17, 2025
Description
2025-6 ADULT FLU VACCINES
Modification timeline
-
November 17, 2025Mod P00003 · Funding Only Action$64.6K
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | Department Of Health And Human Services | March 31, 2026 | $122.8K |
| Four Points Technology, L.L.C. | Department Of Health And Human Services | March 31, 2026 | $246.6K |
| Mckesson Corporation | Department Of Health And Human Services | March 30, 2026 | $9.00M |
| Ase Direct, Inc. | Department Of Health And Human Services | March 30, 2026 | $49.0K |
| Emergent Biosolutions Canada Inc | Department Of Health And Human Services | March 30, 2026 | $256.40M |
| Merck Sharp & Dohme Llc | Department Of Health And Human Services | March 27, 2026 | $361.34M |
Top contractors in NAICS 325412
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Mckesson Corporation | 1,187 | $4.96B |
| 2 | Merck Sharp & Dohme Llc | 26 | $894.71M |
| 3 | Sanofi Vaccines Us Inc. | 57 | $702.38M |
| 4 | Pfizer Inc | 169 | $541.15M |
| 5 | Glaxosmithkline, Llc | 14 | $505.04M |
| 6 | Phlow Corp. | 1 | $105.27M |
| 7 | Exelan Pharmaceuticals Inc | 76 | $104.30M |
| 8 | Seqirus USA Inc | 47 | $59.15M |
| 9 | Emergent Biosolutions Canada Inc | 2 | $53.73M |
| 10 | Mckesson Specialty Distribution Llc | 1 | $51.05M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75D30125D20399?
Contract 75D30125D20399 is a federal contract awarded to Astrazeneca Pharmaceuticals Lp by Department Of Health And Human Services on November 17, 2025 for $5,000 of work classified under PHARMACEUTICAL PREPARATION MANUFACTURING. It has been modified 0 times since the base award.
Who won contract 75D30125D20399?
Astrazeneca Pharmaceuticals Lp won contract 75D30125D20399 from Department Of Health And Human Services.
How much is contract 75D30125D20399 worth?
Contract 75D30125D20399 has obligated $5,000 to date, with a total potential value of $9.05 million if all options are exercised.